Cargando…
The use of platensimycin and platencin to fight antibiotic resistance
Infectious diseases are known as one of the most life-threatening disabilities worldwide. Approximately 13 million deaths related to infectious diseases are reported each year. The only way to combat infectious diseases is by chemotherapy using antimicrobial agents and antibiotics. However, due to u...
Autores principales: | Allahverdiyev, Adil M, Bagirova, Melahat, Abamor, Emrah Sefik, Ates, Sezen Canim, Koc, Rabia Cakir, Miraloglu, Meral, Elcicek, Serhat, Yaman, Serkan, Unal, Gokce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3785399/ https://www.ncbi.nlm.nih.gov/pubmed/24082790 http://dx.doi.org/10.2147/IDR.S25076 |
Ejemplares similares
-
Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer
por: Allahverdiyev, Adil, et al.
Publicado: (2018) -
Conjugation, characterization and toxicity of lipophosphoglycan-polyacrylic acid conjugate for vaccination against leishmaniasis
por: Topuzogullari, Murat, et al.
Publicado: (2013) -
Preparation, characterization and immunological evaluation: canine parvovirus synthetic peptide loaded PLGA nanoparticles
por: Derman, Serap, et al.
Publicado: (2015) -
Polymeric Approach to Adjuvant System in Antibody Production against Leishmaniasis Based on Hybridoma Technology
por: Zorba Yildiz, Asli Pinar, et al.
Publicado: (2022) -
Review of Platensimycin and Platencin: Inhibitors of β-Ketoacyl-acyl Carrier Protein (ACP) Synthase III (FabH)
por: Shang, Ruofeng, et al.
Publicado: (2015)